244 related articles for article (PubMed ID: 21264954)
1. S100B attenuates microglia activation in gliomas: possible role of STAT3 pathway.
Zhang L; Liu W; Alizadeh D; Zhao D; Farrukh O; Lin J; Badie SA; Badie B
Glia; 2011 Mar; 59(3):486-98. PubMed ID: 21264954
[TBL] [Abstract][Full Text] [Related]
2. S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages.
Wang H; Zhang L; Zhang IY; Chen X; Da Fonseca A; Wu S; Ren H; Badie S; Sadeghi S; Ouyang M; Warden CD; Badie B
Clin Cancer Res; 2013 Jul; 19(14):3764-75. PubMed ID: 23719262
[TBL] [Abstract][Full Text] [Related]
3. C6 glioma-conditioned medium induces malignant transformation of mesenchymal stem cells: Possible role of S100B/RAGE pathway.
Tan B; Shen L; Yang K; Huang D; Li X; Li Y; Zhao L; Chen J; Yi Q; Xu H; Tian J; Zhu J
Biochem Biophys Res Commun; 2018 Jan; 495(1):78-85. PubMed ID: 29050939
[TBL] [Abstract][Full Text] [Related]
4. S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain.
Adami C; Bianchi R; Pula G; Donato R
Biochim Biophys Acta; 2004 Dec; 1742(1-3):169-77. PubMed ID: 15590067
[TBL] [Abstract][Full Text] [Related]
5. S100B suppression alters polarization of infiltrating myeloid-derived cells in gliomas and inhibits tumor growth.
Gao H; Zhang IY; Zhang L; Song Y; Liu S; Ren H; Liu H; Zhou H; Su Y; Yang Y; Badie B
Cancer Lett; 2018 Dec; 439():91-100. PubMed ID: 30076898
[TBL] [Abstract][Full Text] [Related]
6. S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release.
Bianchi R; Kastrisianaki E; Giambanco I; Donato R
J Biol Chem; 2011 Mar; 286(9):7214-26. PubMed ID: 21209080
[TBL] [Abstract][Full Text] [Related]
7. Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice.
Zhang L; Alizadeh D; Van Handel M; Kortylewski M; Yu H; Badie B
Glia; 2009 Oct; 57(13):1458-67. PubMed ID: 19306372
[TBL] [Abstract][Full Text] [Related]
8. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells.
Reddy MA; Li SL; Sahar S; Kim YS; Xu ZG; Lanting L; Natarajan R
J Biol Chem; 2006 May; 281(19):13685-13693. PubMed ID: 16551628
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products.
Shanmugam N; Kim YS; Lanting L; Natarajan R
J Biol Chem; 2003 Sep; 278(37):34834-44. PubMed ID: 12837757
[TBL] [Abstract][Full Text] [Related]
10. S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction.
Tsoporis JN; Izhar S; Leong-Poi H; Desjardins JF; Huttunen HJ; Parker TG
Circ Res; 2010 Jan; 106(1):93-101. PubMed ID: 19910580
[TBL] [Abstract][Full Text] [Related]
11. Ligation of RAGE with ligand S100B attenuates ABCA1 expression in monocytes.
Kumar P; Raghavan S; Shanmugam G; Shanmugam N
Metabolism; 2013 Aug; 62(8):1149-58. PubMed ID: 23523156
[TBL] [Abstract][Full Text] [Related]
12. S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha.
Bianchi R; Giambanco I; Donato R
Neurobiol Aging; 2010 Apr; 31(4):665-77. PubMed ID: 18599158
[TBL] [Abstract][Full Text] [Related]
13. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H
J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E increases S100B-mediated microglial activation in an S100B-overexpressing mouse model of pathological aging.
Bialowas-McGoey LA; Lesicka A; Whitaker-Azmitia PM
Glia; 2008 Dec; 56(16):1780-90. PubMed ID: 18649404
[TBL] [Abstract][Full Text] [Related]
15. Neural-activity-dependent release of S100B from astrocytes enhances kainate-induced gamma oscillations in vivo.
Sakatani S; Seto-Ohshima A; Shinohara Y; Yamamoto Y; Yamamoto H; Itohara S; Hirase H
J Neurosci; 2008 Oct; 28(43):10928-36. PubMed ID: 18945900
[TBL] [Abstract][Full Text] [Related]
16. S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner.
Sorci G; Riuzzi F; Agneletti AL; Marchetti C; Donato R
Mol Cell Biol; 2003 Jul; 23(14):4870-81. PubMed ID: 12832473
[TBL] [Abstract][Full Text] [Related]
17. CD166/ALCAM mediates proinflammatory effects of S100B in delayed type hypersensitivity.
von Bauer R; Oikonomou D; Sulaj A; Mohammed S; Hotz-Wagenblatt A; Gröne HJ; Arnold B; Falk C; Luethje D; Erhardt A; Stern DM; Bierhaus A; Nawroth PP
J Immunol; 2013 Jul; 191(1):369-77. PubMed ID: 23729438
[TBL] [Abstract][Full Text] [Related]
18. RAGE regulates immune cell infiltration and angiogenesis in choroidal neovascularization.
Chen M; Glenn JV; Dasari S; McVicar C; Ward M; Colhoun L; Quinn M; Bierhaus A; Xu H; Stitt AW
PLoS One; 2014; 9(2):e89548. PubMed ID: 24586862
[TBL] [Abstract][Full Text] [Related]
19. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains.
Leclerc E; Fritz G; Weibel M; Heizmann CW; Galichet A
J Biol Chem; 2007 Oct; 282(43):31317-31. PubMed ID: 17726019
[TBL] [Abstract][Full Text] [Related]
20. S100B binding to RAGE in microglia stimulates COX-2 expression.
Bianchi R; Adami C; Giambanco I; Donato R
J Leukoc Biol; 2007 Jan; 81(1):108-18. PubMed ID: 17023559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
